Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Perspective - Journal of Medical Oncology and Therapeutics (2024) Volume 9, Issue 4

Hepatocellular carcinoma disciplines

Giuseppe Nucci*

Department of Pharmacy, Nutritional and Health Sciences, University of Calabria, Arcavacata di Rende, Italy.

*Corresponding Author:
Giuseppe Nucci
Department of Pharmacy, Nutritional and Health Sciences
University of Calabria, Arcavacata di Rende, Italy.
E-mail: nucci@uncal.it

Received: 17-May-2024, Manuscript No JMOT-24-139923; Editor assigned: 23-May-2024, PreQC No.JMOT-24-139923PQ); Reviewed: 02-June-2024, QC No JMOT-24-139923; Revised: 09-June-2024, Manuscript No. JMOT-24-139923(R); Published: 03-July-2024, DOI: 10.35841/jmot-9.4.213

Citation: Nucci G. Hepatocellular carcinoma disciplines. J Med Oncl Ther. 2024;9(4):213.

Visit for more related articles at Journal of Medical Oncology and Therapeutics

Introduction

Hepatocellular carcinoma (HCC) is a complex disease that requires interdisciplinary approaches for comprehensive management. Various medical disciplines play crucial roles in its diagnosis, treatment, and ongoing care.

Specialists in hepatology focus on the liver, diagnosing liver diseases like HCC through imaging studies, blood tests, and biopsies. They also manage underlying liver conditions such as cirrhosis, which is a major risk factor for HCC [1].

Oncologists specialize in cancer diagnosis and treatment. They play a key role in staging HCC, determining the extent of the disease, and developing treatment plans, which may include surgery, chemotherapy, targeted therapy, immunotherapy, or a combination. Radiologists interpret imaging studies such as ultrasound, CT scans, MRI, and PET scans to detect liver tumors and assess their size, location, and spread. They provide crucial information for staging and treatment planning [2].

Surgical oncologists perform procedures such as liver resection, liver transplant, and tumor ablation to remove or destroy cancerous tissue. They aim to remove the tumor while preserving as much healthy liver tissue as possible [3].

Interventional radiologists use minimally invasive techniques such as radiofrequency ablation, transarterial chemoembolization (TACE), and radioembolization to treat HCC. These procedures can target and destroy tumors with fewer risks and shorter recovery times than traditional surgery [4].

Pathologists analyze tissue samples obtained during biopsy or surgery to confirm the diagnosis of HCC and provide information about tumor grade, stage, and molecular characteristics. This information helps guide treatment decisions [5,6].

Gastroenterologists may be involved in the management of HCC, particularly in cases where the tumor is detected at an early stage or in patients with underlying liver disease. They can provide supportive care and monitor for complications [7].

Palliative care specialists focus on improving the quality of life for patients with advanced HCC by managing symptoms such as pain, nausea, and fatigue. They provide support for patients and their families throughout the treatment process [8].

Nutritionists play a critical role in the care of patients with HCC, especially those with cirrhosis or undergoing treatment. They provide dietary guidance to optimize liver function, maintain a healthy weight, and manage side effects of therapy [9].

Oncologists specialize in the diagnosis and treatment of cancer. They play a central role in managing carcinoma patients, coordinating treatment plans that may include surgery, chemotherapy, radiation therapy, immunotherapy, or targeted therapy. Pathologists analyze tissue samples to diagnose cancer accurately. In the case of carcinoma, pathologists examine biopsy specimens to determine the type of carcinoma present, its grade, and other important characteristics that influence treatment decisions. Oncology social workers assist carcinoma patients and their families in navigating the complex healthcare system, accessing resources, and coping with practical and emotional challenges associated with the disease [10].

Conclusion

These disciplines, working collaboratively within a multidisciplinary team, contribute to comprehensive care for carcinoma patients, emphasizing personalized approaches tailored to individual needs and circumstances. By leveraging the expertise of diverse specialties, healthcare professionals can optimize outcomes and improve the overall well-being of individuals affected by carcinoma. Collaboration among these disciplines is essential for delivering personalized, multidisciplinary care to patients with HCC, improving outcomes and quality of life..

References

  1. Salem R, Padia SA, Lam M, et al. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur Journal of Nuclear Medicine and Molecular Imaging. 2023;50(2):328-343.

    2. Indexed at, Google Scholar, Cross Ref

  2. Paul S, Min E, Benson KK,  et al. Elkhatib RT. Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC).

    3. Indexed at, Google Scholar, Cross Ref

  3. Lubel JS, Roberts SK, Howell J, et al. Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia. Internal Medicine Journal. 2021;51(2):181-188.

    4. Indexed at, Google Scholar, Cross Ref

  4. Chen M, Wang H, Guo H,  et al. Systematic investigation of biocompatible cationic polymeric nucleic acid carriers for immunotherapy of hepatocellular carcinoma. Cancers. 2021;14(1):85.

    5. Indexed at, Google Scholar, Cross Ref

  5. Oh JH, Sinn DH. Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives. Journal of Liver Cancer. 2024;24(1):47-56.

    6. Indexed at, Google Scholar, Cross Ref

  6. Lucas L, Philip PA, Gandee M, et al. Understanding practices and gaps in multidisciplinary hepatocellular carcinoma (HCC) care within the community oncology setting.

    7. Indexed at, Google Scholar, Cross Ref

  7. Dhir M, Melin AA, Douaiher J, et al. A review and update of treatment options and controversies in the management of hepatocellular carcinoma. Annals of surgery. 2016;263(6):1112-1115.

    8. Indexed at, Google Scholar, Cross Ref

  8. Chirikov VV, Mullins CD, Hanna N, et al. Multispecialist care and mortality in hepatocellular carcinoma. American Journal of Clinical Oncology. 2015;38(6):557-563.

    9. Indexed at, Google Scholar, Cross Ref

  9. Liu Ping LP, Mu YongPing MY, Liu ChengHai LC. Clinical and basic progress of traditional Chinese medicine in chronic liver disease.

    10. Indexed at, Google Scholar

  10. Su K, Huang W, Li X, et al. Evaluation of lactate dehydrogenase and alkaline phosphatase as predictive biomarkers in the prognosis of hepatocellular carcinoma and development of a new nomogram. Journal of hepatocellular carcinoma. 2023:69-79.

    11. Indexed at, Google Scholar, Cross Ref

Get the App